Another recent study showed a global decrease in microRNA levels in LSC-enriched CD34+CD38−CD26+ and HSC from CML-CP patients compared to those from healthy donors HSC [143]. The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.